welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Hereditary Colorectal Cancer Syndromes: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the Familial Risk–Colorectal Cancer: European Society for Medical Oncology Clinical Practice Guidelines
source: Journal Of Clinical Oncology
year: 2015
authors: Elena M. Stoffel, Pamela B. Mangu, Stephen B. Gruber, Stanley R. Hamilton, Matthew F. Kalady, Michelle Wan Yee Lau, Karen H. Lu, Nancy Roach, Paul J. Limburg
summary/abstract:Purpose:
To provide recommendations on prevention, screening, genetics, treatment, and management for people at risk for hereditary colorectal cancer (CRC) syndromes. The American Society of Clinical Oncology (ASCO) has a policy and set of procedures for endorsing clinical practice guidelines that have been developed by other professional organizations. Methods The Familial Risk–Colorectal Cancer: European Society for Medical Oncology Clinical Practice Guideline published in 2013 on behalf of the European Society for Medical Oncology (ESMO) Guidelines Working Group in Annals of Oncology was reviewed for evelopmental rigor by methodologists, with content and recommendations reviewed by an ASCO endorsement panel.
Results:
The ASCO endorsement panel determined that the recommendations of the ESMO guidelines are clear, thorough, and based on the most relevant scientific evidence. The ASCO panel endorsed the ESMO guidelines and added a few qualifying statements. Recommendations Approximately 5% to 6% of patient cases of CRC are associated with germline mutations that confer an inherited predisposition for cancer. The possibility of a hereditary cancer syndrome
should be assessed for every patient at the time of CRC diagnosis. A diagnosis of Lynch syndrome, familial adenomatous polyposis, or another genetic syndrome can influence clinical management for patients with CRC and their family members. Screening for hereditary cancer syndromes in patients with CRC should include review of personal and family histories and testing of tumors for DNA mismatch repair deficiency and/or microsatellite instability. Formal genetic
evaluation is recommended for individuals who meet defined criteria.
read more
expertly curated content related to this topic
-
Sulindac/Erlotinib Combo Tested in Patients with Familial Adenomatous PolyposisA lower duodenal polyp burden was seen a...
-
Strategy for Surgery in Familial Adenomatous Polyposis Patients with Invasive Colorectal CancerPURPOSE : Total proctocolectomy with ile...
-
Non Steroidal Anti-Inflammatory Drugs (NSAID) and Aspirin for Preventing Colorectal Adenomas and CarcinomasBACKGROUND : There is evidence from expe...
-
Familial Adenomatous Polyposis: A Bibliography and Dictionary for Physicians, Patients, and Genome ResearchersThe book covers these subjects among oth...
-
Best Practice Guidelines for Molecular Analysis of Colorectal Polyposis: Familial Adenomatous Polyposis Coli (FAP) a...Background:. UK Clinical Molecular Genet...
-
A Germline Homozygous Loss-of-Function Mutation in the Base Excision Repair Gene NTHL1 Causes Adenomatous Polyposis ...Abstract Introduction: Patients diagn...
-
Genomics of Hereditary Colorectal Cancer: Lessons Learnt from 25 Years of the Singapore Polyposis RegistryINTRODUCTION : The Singapore Polyposis R...